vs
Side-by-side financial comparison of Taysha Gene Therapies, Inc. (TSHA) and Worksport Ltd (WKSP). Click either name above to swap in a different company.
Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $4.7M, roughly 1.2× Worksport Ltd). On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 62.0%). Over the past eight quarters, Worksport Ltd's revenue compounded faster (204.2% CAGR vs 26.8%).
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
Worksport LtdWKSPEarnings & Financial Report
Worksport Ltd is a cleantech company specializing in portable solar energy solutions and custom truck bed accessories. Its core offerings include solar-powered tonneau covers for pickup trucks and portable mobile power stations, serving the North American automotive aftermarket and consumer clean energy segments.
TSHA vs WKSP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5M | $4.7M |
| Net Profit | $-27.9M | — |
| Gross Margin | — | 30.1% |
| Operating Margin | -516.0% | -129.6% |
| Net Margin | -507.8% | — |
| Revenue YoY | 171.3% | 62.0% |
| Net Profit YoY | -48.3% | — |
| EPS (diluted) | $-0.08 | $-0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5M | $4.7M | ||
| Q3 25 | $0 | $5.0M | ||
| Q2 25 | $2.0M | $4.1M | ||
| Q1 25 | $2.3M | $2.2M | ||
| Q4 24 | $2.0M | $2.9M | ||
| Q3 24 | $1.8M | $3.1M | ||
| Q2 24 | $1.1M | $1.9M | ||
| Q1 24 | $3.4M | $512.6K |
| Q4 25 | $-27.9M | — | ||
| Q3 25 | $-32.7M | $-4.9M | ||
| Q2 25 | $-26.9M | $-3.7M | ||
| Q1 25 | $-21.5M | $-4.5M | ||
| Q4 24 | $-18.8M | — | ||
| Q3 24 | $-25.5M | $-4.1M | ||
| Q2 24 | $-20.9M | $-4.0M | ||
| Q1 24 | $-24.1M | $-3.7M |
| Q4 25 | — | 30.1% | ||
| Q3 25 | — | 31.3% | ||
| Q2 25 | — | 26.4% | ||
| Q1 25 | — | 17.7% | ||
| Q4 24 | — | 11.1% | ||
| Q3 24 | — | 7.9% | ||
| Q2 24 | — | 15.4% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | -516.0% | -129.6% | ||
| Q3 25 | — | -95.6% | ||
| Q2 25 | -1347.1% | -88.1% | ||
| Q1 25 | -930.5% | -190.0% | ||
| Q4 24 | -985.8% | -137.0% | ||
| Q3 24 | -1448.4% | -125.1% | ||
| Q2 24 | -1915.4% | -203.5% | ||
| Q1 24 | -713.3% | -709.9% |
| Q4 25 | -507.8% | — | ||
| Q3 25 | — | -98.3% | ||
| Q2 25 | -1353.6% | -91.0% | ||
| Q1 25 | -935.2% | -199.1% | ||
| Q4 24 | -929.0% | — | ||
| Q3 24 | -1427.5% | -132.4% | ||
| Q2 24 | -1882.0% | -208.9% | ||
| Q1 24 | -705.4% | -724.6% |
| Q4 25 | $-0.08 | $-0.65 | ||
| Q3 25 | $-0.09 | $-0.75 | ||
| Q2 25 | $-0.09 | $-0.71 | ||
| Q1 25 | $-0.08 | $-1.05 | ||
| Q4 24 | $-0.07 | $-1.14 | ||
| Q3 24 | $-0.10 | $-1.40 | ||
| Q2 24 | $-0.09 | $-1.55 | ||
| Q1 24 | $-0.10 | $-1.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $319.8M | $5.9M |
| Total DebtLower is stronger | — | $2.7M |
| Stockholders' EquityBook value | $246.9M | $22.9M |
| Total Assets | $343.3M | $30.7M |
| Debt / EquityLower = less leverage | — | 0.12× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $319.8M | $5.9M | ||
| Q3 25 | $297.3M | $3.8M | ||
| Q2 25 | $312.8M | $1.4M | ||
| Q1 25 | $116.6M | $5.1M | ||
| Q4 24 | $139.0M | $4.9M | ||
| Q3 24 | $157.7M | $1.9M | ||
| Q2 24 | $172.7M | $3.4M | ||
| Q1 24 | $124.0M | $3.5M |
| Q4 25 | — | $2.7M | ||
| Q3 25 | — | $2.9M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $246.9M | $22.9M | ||
| Q3 25 | $219.0M | $19.8M | ||
| Q2 25 | $248.7M | $17.3M | ||
| Q1 25 | $55.1M | $20.1M | ||
| Q4 24 | $71.5M | $17.4M | ||
| Q3 24 | $88.8M | $16.4M | ||
| Q2 24 | $108.9M | $19.1M | ||
| Q1 24 | $53.8M | $18.9M |
| Q4 25 | $343.3M | $30.7M | ||
| Q3 25 | $316.6M | $27.0M | ||
| Q2 25 | $333.3M | $23.6M | ||
| Q1 25 | $138.4M | $26.7M | ||
| Q4 24 | $160.4M | $25.7M | ||
| Q3 24 | $180.2M | $24.9M | ||
| Q2 24 | $200.4M | $27.2M | ||
| Q1 24 | $153.0M | $27.3M |
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-26.7M | $-6.1M |
| Free Cash FlowOCF − Capex | — | $-6.3M |
| FCF MarginFCF / Revenue | — | -132.4% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-26.7M | $-6.1M | ||
| Q3 25 | $-24.2M | $-4.3M | ||
| Q2 25 | $-20.2M | $-3.1M | ||
| Q1 25 | $-22.0M | $-3.8M | ||
| Q4 24 | $-18.3M | $-2.2M | ||
| Q3 24 | $-21.6M | $-1.5M | ||
| Q2 24 | $-21.5M | $-3.6M | ||
| Q1 24 | $-19.8M | $-2.8M |
| Q4 25 | — | $-6.3M | ||
| Q3 25 | $-24.3M | $-4.6M | ||
| Q2 25 | — | $-3.2M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | $-18.3M | $-2.2M | ||
| Q3 24 | $-21.6M | $-1.7M | ||
| Q2 24 | $-21.7M | $-3.7M | ||
| Q1 24 | $-19.9M | $-3.0M |
| Q4 25 | — | -132.4% | ||
| Q3 25 | — | -92.1% | ||
| Q2 25 | — | -77.1% | ||
| Q1 25 | — | -180.4% | ||
| Q4 24 | -905.5% | -75.4% | ||
| Q3 24 | -1210.9% | -54.5% | ||
| Q2 24 | -1951.9% | -195.1% | ||
| Q1 24 | -584.5% | -586.7% |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 7.3% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | 0.1% | 0.9% | ||
| Q3 24 | 2.0% | 5.3% | ||
| Q2 24 | 18.1% | 6.4% | ||
| Q1 24 | 4.1% | 41.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
